Antiphospholipid syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …
Antiphospholipid syndrome
LR Sammaritano - Best Practice & Research Clinical Rheumatology, 2020 - Elsevier
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …
Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review
J Alijotas-Reig, E Esteve-Valverde… - Journal of clinical …, 2022 - mdpi.com
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …
16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …
[HTML][HTML] The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
Abstract Beta-2-Glycoprotein I (β2GPI) plays a number of essential roles throughout the
body. β2GPI, C-reactive protein and thrombomodulin are the only three proteins that …
body. β2GPI, C-reactive protein and thrombomodulin are the only three proteins that …
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases
J Alijotas-Reig, E Esteve-Valverde… - Autoimmunity …, 2019 - Elsevier
Aim To analyse the clinical features, laboratory data and foetal-maternal outcomes, and
follow them up on a cohort of 1000 women with obstetric antiphospholipid syndrome …
follow them up on a cohort of 1000 women with obstetric antiphospholipid syndrome …
Managing antiphospholipid syndrome in pregnancy
K Schreiber, BJ Hunt - Thrombosis research, 2019 - Elsevier
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence
of antiphospholipid antibodies (aPL). The antibodies currently included in the classification …
of antiphospholipid antibodies (aPL). The antibodies currently included in the classification …
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates
Repurposing of antirheumatic drugs has garnered global attention. The aim of this article is
to overview available evidence on the use of widely used antirheumatic drugs …
to overview available evidence on the use of widely used antirheumatic drugs …
Antiphospholipid syndrome: an update on risk factors for pregnancy outcome
Background The optimal treatment of women with primary antiphospholipid syndrome (APS)
is still debated. About 20–30% of women with APS remain unable to give birth to healthy …
is still debated. About 20–30% of women with APS remain unable to give birth to healthy …
New ideas for the prevention and treatment of preeclampsia and their molecular inspirations
A Sakowicz, M Bralewska… - International Journal of …, 2023 - mdpi.com
Preeclampsia (PE) is a pregnancy-specific disorder affecting 4–10% of all expectant women.
It greatly increases the risk of maternal and foetal death. Although the main symptoms …
It greatly increases the risk of maternal and foetal death. Although the main symptoms …